Key facts
- 3billion launched 3B-NEO, a genomic newborn screening service.
- The service screens 595 clinically actionable genetic conditions.
- It targets childhood-onset conditions where early intervention may improve outcomes.
- The service is intended for maternity hospitals, obstetrics practices, newborn care providers, pediatric clinics, and families.
Early detection of genetic conditions in newborns can significantly improve treatment outcomes and long-term health. Genomic screening at birth offers the potential to identify a wide range of conditions, enabling timely interventions and personalized care strategies for affected children and their families.